Recent reports have demonstrated increased secretion of LL-37 in ovarian tumors compared to normal ovary cells, implicating the role of LL-37 in ovarian cancer development (Fig. 2) (Coffelt et al. 2008). This evidence concerns the gene CAMP and ovarian carcinoma.